Rapid Response
Use of Magnesium for the Treatment of Acute Onset Atrial Fibrillation
Abstract
Use of Magnesium for the Treatment of Acute Onset Atrial Fibrillation
A common worldwide health problem is atrial fibrillation, being the most common arrhythmia treated in clinical practice. Recommended treatment for patients with severe atrial fibrillation includes the use of β-blockers and channel blockers to control the rate of the heart. This review discusses two studies that produce different outcomes concerning the use of magnesium in rhythm and rate control and the need to question both studies in regards to lack of addressing magnesium's usefulness in treating acute atrial fibrillation.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
